Scientists train Patients' own immune cells to hunt down HPV cancers
NCT ID NCT02379520
Summary
This early-phase study is testing a new treatment for cancers linked to the human papillomavirus (HPV) that have come back or not responded to standard care. Researchers take a patient's own immune cells, grow and modify them in a lab to better recognize and attack HPV-infected cancer cells, then infuse them back into the patient. The main goals are to find a safe dose, see how long the cells last, and check if they can help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.